Nymalize FDA Approval History
FDA Approved: Yes (First approved May 10, 2013)
Brand name: Nymalize
Generic name: nimodipine
Dosage form: Oral Solution
Company: Azurity Pharmaceuticals, Inc.
Treatment for: Subarachnoid Hemorrhage
Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following subarachnoid hemorrhage.
Development timeline for Nymalize
| Date | Article |
|---|---|
| Sep 3, 2024 | Approval Azurity Pharmaceuticals, Inc. Announces FDA Approval of Nymalize (nimodipine) Oral Solution 30 mg/5 mL Prefilled ENFit® Syringe |
| May 13, 2013 | Approval Arbor Pharmaceuticals Announces FDA Approval of Nymalize |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.